Back to search

Article

Immunohistochemical Study of Histone Protein 3 Modification in Pediatric Osteosarcoma Identifies Reduced H3K27me3 as a Marker of Poor Treatment Response

2023-09-15

Abstract excerpt

<h4>Summary/Abstract</h4> The most common pediatric primary malignant bone tumor, osteosarcoma, is often described as genetically non-recurrent and heterogeneous. Neoadjuvant chemotherapy is typically followed by resection and assessment of treatment response, which helps inform prognosis. Identifying biomarkers that may impact chemotherapy response and survival could aid in upfront risk stratification and identi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a1077a0-619a-5ed4-beff-36685820be95
DOI
10.1101/2023.09.13.23295510
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunohistochemical Study of Histone Protein 3 Modification in Pediatric Osteosarcoma Identifies Reduced H3K27me3 as a Marker of Poor Treatment ResponseDOI 10.1101/2023.09.13.23295510
Select a neighboring publication to make it the new centre.